NanoViricides, Inc. Common Stock (NY:NNVC)

1.670 -0.030 (-1.76%)

Streaming Delayed Price Updated: 1:32 PM EDT, Oct 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NanoViricides, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

COVID-19 Variants: What the Future Could Look Like After the Pandemic

July 14, 2021

Photo by Martin Sanchez on Unsplash Since the coronavirus pandemic shut down the world, scientists have clamored to develop vaccines to prevent the spread and medicines that will...

Via Benzinga

Nanomedicine Company Makes "Nanomachines" that Attack Viruses

June 28, 2021

Photo by Fusion Medical Animation on Unsplash Ever since scientists discovered the existence of viruses in the late 1800s, virologists have tried to understand and prevent them...

Via Benzinga

45 Biggest Movers From Yesterday

June 24, 2021

Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares surged 44.8% to close at $6.50 on Wednesday after the company reported topline Phase 2 bone mineral density data for EB613. First...

Via Benzinga

Nanomedicine Company Makes "Nanomachines" that Attack Viruses

June 22, 2021

Photo by Fusion Medical Animation on Unsplash Ever since scientists discovered the existence of viruses in the late 1800s, virologists have tried to understand and prevent them...

Via Benzinga

NanoViricides Review: What you Need to Know About the Company

June 22, 2021

With the coronavirus changing the world in 2020, it makes sense that there’s a spotlight on science to prevent viruses from growing into pandemics. While Pfizer (NYSE: PFE)...

Via Benzinga

NanoViricides Has Filed Quarterly Report for Period Ending March 31, 2021 - Has Sufficient Cash, Coronavirus Drug Candidate Moving Towards IND

May 17, 2021

SHELTON, CT / ACCESSWIRE / May 17, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel...

From NanoViricides, Inc.

Via AccessWire

Topics Regulatory Compliance

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.